Correlation Between SpringWorks Therapeutics and Regenxbio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SpringWorks Therapeutics and Regenxbio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SpringWorks Therapeutics and Regenxbio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SpringWorks Therapeutics and Regenxbio, you can compare the effects of market volatilities on SpringWorks Therapeutics and Regenxbio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SpringWorks Therapeutics with a short position of Regenxbio. Check out your portfolio center. Please also check ongoing floating volatility patterns of SpringWorks Therapeutics and Regenxbio.

Diversification Opportunities for SpringWorks Therapeutics and Regenxbio

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between SpringWorks and Regenxbio is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding SpringWorks Therapeutics and Regenxbio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regenxbio and SpringWorks Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SpringWorks Therapeutics are associated (or correlated) with Regenxbio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regenxbio has no effect on the direction of SpringWorks Therapeutics i.e., SpringWorks Therapeutics and Regenxbio go up and down completely randomly.

Pair Corralation between SpringWorks Therapeutics and Regenxbio

Given the investment horizon of 90 days SpringWorks Therapeutics is expected to generate 1.29 times less return on investment than Regenxbio. But when comparing it to its historical volatility, SpringWorks Therapeutics is 3.47 times less risky than Regenxbio. It trades about 0.26 of its potential returns per unit of risk. Regenxbio is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  667.00  in Regenxbio on April 20, 2025 and sell it today you would earn a total of  202.00  from holding Regenxbio or generate 30.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy80.65%
ValuesDaily Returns

SpringWorks Therapeutics  vs.  Regenxbio

 Performance 
       Timeline  
SpringWorks Therapeutics 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Over the last 90 days SpringWorks Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly unsteady basic indicators, SpringWorks Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Regenxbio 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Regenxbio are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Regenxbio showed solid returns over the last few months and may actually be approaching a breakup point.

SpringWorks Therapeutics and Regenxbio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SpringWorks Therapeutics and Regenxbio

The main advantage of trading using opposite SpringWorks Therapeutics and Regenxbio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SpringWorks Therapeutics position performs unexpectedly, Regenxbio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenxbio will offset losses from the drop in Regenxbio's long position.
The idea behind SpringWorks Therapeutics and Regenxbio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios